(Hypertension. 1996;28:907-911.)
© 1996 American Heart Association, Inc.
Articles |
the Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, England.
The angiotensinogen gene locus (1q42-43) has been linked to hypertension in affected relative-pair studies (including a previous UK study), but the role of the Met
Thr polymorphism at position 235 remains controversial. Using this marker, we investigated the relationship between angiotensinogen genotype and blood pressure in two data sets from the East Anglia region of the United Kingdom. Two hundred twenty-three untreated hypertensive and 187 normotensive control subjects were recruited through local general practices. Blood pressure (including pretreatment measurements in the hypertensive group), age, sex, body mass index, alcohol consumption, cholesterol level, and angiotensinogen genotype were recorded for all subjects. The influence of angiotensinogen genotype on blood pressure was assessed with a general linear model ANOVA with adjustment for age, sex, body mass index, and alcohol consumption. There was no evidence for an association between angiotensinogen genotype and blood pressure level in either the hypertensive or normotensive data set. Angiotensinogen genotype did not influence blood pressure in subjects aged <50 years, women, or those with a body mass index <26 kg/m2. We conclude that the angiotensinogen Met
Thr polymorphism is not a marker for blood pressure level in these East Anglian subjects. Further studies are required to confirm the involvement of the 1q locus in the development of hypertension in UK subjects and to delineate the functional variant(s) in this chromosomal region that influences blood pressure.
Key Words: angiotensinogen hypertension, genetic renin-angiotensin system genes
This article has been cited by other articles:
![]() |
Y. Tabel, A. Berdeli, S. Mir, E. Serdaroglu, and E. Ytlmaz Effects of Genetic Polymorphisms of the Renin-Angiotensin System in Children with Nephrotic Syndrome Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 138 - 144. [Abstract] [PDF] |
||||
![]() |
A. A. Sethi, B. G. Nordestgaard, and A. Tybjaerg-Hansen Angiotensinogen Gene Polymorphism, Plasma Angiotensinogen, and Risk of Hypertension and Ischemic Heart Disease: A Meta-Analysis Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1269 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cvetkovic, H. L. Keen, X. Zhang, D. Davis, B. Yang, and C. D. Sigmund Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse Physiol Genomics, December 3, 2002; 11(3): 253 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sethi, B. G. Nordestgaard, B. Agerholm-Larsen, E. Frandsen, G. Jensen, and A. Tybjarg-Hansen Angiotensinogen Polymorphisms and Elevated Blood Pressure in the General Population : The Copenhagen City Heart Study Hypertension, March 1, 2001; 37(3): 875 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Padmanabhan, S. Padmanabhan, and J. M. Connell Genetic basis of cardiovascular disease -- the renin-angiotensin-aldosterone system as a paradigm Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 316 - 324. [PDF] |
||||
![]() |
B. Cvetkovic, B. Yang, R. A. Williamson, and C. D. Sigmund Appropriate Tissue- and Cell-specific Expression of a Single Copy Human Angiotensinogen Transgene Specifically Targeted Upstream of the HPRT Locus by Homologous Recombination J. Biol. Chem., January 14, 2000; 275(2): 1073 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brand, N. Chatelain, B. Keavney, M. Caulfield, L. Citterio, J. Connell, D. Grobbee, S. Schmidt, H. Schunkert, H. Schuster, et al. Evaluation of the Angiotensinogen Locus in Human Essential Hypertension : A European Study Hypertension, March 1, 1998; 31(3): 725 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kunz, R. Kreutz, J. Beige, A. Distler, and A. M. Sharma Association Between the Angiotensinogen 235T-Variant and Essential Hypertension in Whites : A Systematic Review and Methodological Appraisal Hypertension, December 1, 1997; 30(6): 1331 - 1337. [Abstract] [Full Text] |
||||
![]() |
P. Corvol and X. Jeunemaitre Molecular Genetics of Human Hypertension: Role of Angiotensinogen Endocr. Rev., October 1, 1997; 18(5): 662 - 677. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |